Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG) — Camille Moreau-Bachelard (2022) | RDL Network
Patterns of care and outcomes of 417 patients with METAstatic SYNovial sarcoma (METASYN): real-life data from the French Sarcoma Group (FSG)
Article 2022 en
Authors
CM
Camille Moreau-Bachelard
LC
L. Campion
MT
Maud Toulmonde
Abstract
1 min read
The outcome of patients with metastatic SS is influenced by local treatment, management in reference centers, and cytotoxic treatments given in the perioperative and metastatic setting.
Maud Toulmonde, Derek Dinart, Mehdi Brahmi, Benjamin Verret, Myriam Jean‐Denis, Françoise Ducimetière, G. Désolneux, Pierre Méeus, Jean Palussière, Xavier Buy, Amine Bouhamama, P. Gillon, Armelle Dufresne, Clémence Hénon, François Le Loarer, Marie Karanian, Carine Ngo, Simone Mathoulin‐Pélissier, Carine Bellera, Axel Le Cesne, Jean Yves Blay, Antoîne Italiano
Camille Moreau-Bachelard, Maud Toulmonde, Axel Le Cesne, Mehdi Brahmi, Antoîne Italiano, Olivier Mir, Sophie Piperno‐Neumann, Valérie Laurence, Nelly Firmin, Christine Chevreau, François Bertucci, B. Narciso, Pascale Dubray‐Longeras, Corinne Delcambre, Esma Saâda-Bouzid, P Soulié, Christophe Perrin, Jean Yves Blay, Emmanuelle Bompas
Jean‐Loup Mouysset, David Spiegel, Barbara L. Andersen, Emmanuel Kinne, Pierre Caillat, Laetiia Dewolf, Charles Saunders, N. Rosati, T. Bouillet, Antoine Demonceaux, Philippe Orts, Jean Yves Blay
Discussion(0)
No comments yet. Be the first to comment.